Reaction
Amyloidosis reporting signals
As of the last recalculation, Amyloidosis appears in 1,705 FAERS reports alongside 34 co-occurring drug terms. The strongest observed disproportionality signal is TAFAMIDIS (PRR 124.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tafamidis | 112 | 124.2 | 125.4 |
| Bortezomib | 230 | 36.1 | 36.2 |
| Thalidomide | 84 | 29.3 | 29.4 |
| Canakinumab | 24 | 27.5 | 27.5 |
| Melphalan Hydrochloride | 51 | 25.6 | 25.6 |
| Melphalan | 46 | 25.3 | 25.4 |
| Anakinra | 27 | 20.2 | 20.2 |
| Daratumumab | 54 | 17.0 | 17.0 |
| Carfilzomib | 36 | 15.9 | 15.9 |
| Eplerenone | 13 | 12.5 | 12.5 |
| Metolazone | 11 | 12.0 | 12.0 |
| Ixazomib | 27 | 11.6 | 11.6 |
| Dexamethasone 1.5 Mg | 239 | 11.4 | 11.4 |
| Insulin Glargine-Yfgn | 20 | 11.3 | 11.3 |
| Dexamethasone | 239 | 11.3 | 11.3 |
| Chlorthalidone | 10 | 10.6 | 10.6 |
| Lenalidomide | 271 | 9.1 | 9.1 |
| Pomalidomide | 69 | 8.5 | 8.5 |
| Minocycline | 8 | 8.4 | 8.4 |
| Cyclophosphamide Injection, Solution | 113 | 8.3 | 8.3 |
| Cyclophosphamide | 113 | 8.3 | 8.3 |
| Cyclophosphamide For Injection | 113 | 8.3 | 8.3 |
| Apixaban | 43 | 8.0 | 8.0 |
| Alteplase | 8 | 6.5 | 6.5 |
| Droxidopa | 11 | 6.3 | 6.3 |
| Bendamustine Hcl | 7 | 5.5 | 5.5 |
| Inclisiran | 3 | 4.6 | 4.6 |
| Sevelamer Carbonate | 4 | 4.3 | 4.3 |
| Tolvaptan | 5 | 4.2 | 4.2 |
| Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 10 | 3.9 | 3.9 |
| Sacubitril And Valsartan | 36 | 3.8 | 3.8 |
| Ixekizumab | 11 | 3.6 | 3.6 |
| Vemurafenib | 3 | 3.1 | 3.1 |
| Tapentadol Hydrochloride | 5 | 1.8 | 1.8 |